UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A comprehensive echocardiographic method for risk stratification in pulmonary arterial hypertension

The European respiratory journal, 2020-09, Vol.56 (3), p.2000513

2020

Volltextzugriff (PDF)

Understanding Heart Failure

Heart failure clinics, 2017-01, Vol.13 (1), p.1-19

2017

Volltextzugriff (PDF)

Serum Albumin Is a Marker of Myocardial Fibrosis, Adverse Pulsatile Aortic Hemodynamics, and Prognosis in Heart Failure With Preserved Ejection Fraction

Journal of the American Heart Association, 2020-02, Vol.9 (3), p.e014716-e014716

2020

Volltextzugriff (PDF)

Right ventricular response to pulsatile load is associated with early right heart failure and mortality after left ventricular assist device

The Journal of heart and lung transplantation, 2017-01, Vol.36 (1), p.97-105

2017

Volltextzugriff (PDF)

Galectin-3 Levels Are Elevated and Predictive of Mortality in Pulmonary Hypertension

Heart, lung & circulation, 2017-11, Vol.26 (11), p.1208-1215

2017

Volltextzugriff (PDF)

Pulmonary Hypertension in Heart Failure Patients

Cardiac failure review, 2020-04, Vol.6, p.e05-e05

2020

Volltextzugriff (PDF)

Pulmonary Hypertension in Advanced Heart Failure: Assessment and Management of the Failing RV and LV

Current heart failure reports, 2019-10, Vol.16 (5), p.119-129

2019

Volltextzugriff (PDF)

Outcomes in World Health Organization Group II Pulmonary Hypertension: Mortality and Readmission Trends With Systolic and Preserved Ejection Fraction–Induced Pulmonary Hypertension

Journal of cardiac failure, 2014-07, Vol.20 (7), p.467-475

2014

Volltextzugriff (PDF)

Novel Risk Model to Predict Emergency Department Associated Mortality for Patients Supported With a Ventricular Assist Device: The Emergency Department-Ventricular Assist Device Risk Score

Journal of the American Heart Association, 2022-01, Vol.11 (2), p.e020942-e020942

2022

Volltextzugriff (PDF)

Predicting Long Term Outcome in Patients Treated With Continuous Flow Left Ventricular Assist Device: The Penn—Columbia Risk Score

Journal of the American Heart Association, 2018-03, Vol.7 (6), p.n/a

2018

Volltextzugriff (PDF)

An Increasing Burden of Disease: Emergency Department Visits Among Patients With Ventricular Assist Devices From 2010 to 2017

Journal of the American Heart Association, 2021-02, Vol.10 (4), p.e018035

2021

Volltextzugriff (PDF)

Focused Cardiac Ultrasound in Place of Repeat Echocardiography: Reliability and Cost Implications

Journal of the American Society of Echocardiography, 2015-09, Vol.28 (9), p.1053-1059

2015

Volltextzugriff (PDF)

Comparison of Causes of Death After Heart Transplantation in Patients With Left Ventricular Ejection Fractions ≤35% Versus >35

The American journal of cardiology, 2016-04, Vol.117 (8), p.1322-1326

2016

Volltextzugriff (PDF)

The effect of transfusion of blood products on ventricular assist device support outcomes

ESC Heart Failure, 2020-12, Vol.7 (6), p.3573-3581

2020

Volltextzugriff (PDF)

Understanding Heart Failure

Cardiac electrophysiology clinics, 2015-12, Vol.7 (4), p.557-575

2015

Volltextzugriff (PDF)

Symptom phenotypes in pulmonary arterial hypertension: The PAH “symptome”

Pulmonary circulation, 2022-07, Vol.12 (3), p.e12135-n/a

2022

Volltextzugriff (PDF)

Cold at the Core: Osborn Waves in Neurosarcoidosis-Induced Central Hypothermia

Case reports in cardiology, 2019-01, Vol.2019 (2019), p.1-3

2019

Volltextzugriff (PDF)

Systemic arterial properties in pulmonary hypertension

Pulmonary circulation, 2021-10, Vol.11 (4), p.1-3

2021

Volltextzugriff (PDF)

Changes in Pulmonary Vascular Resistance after Left Ventricular Assist Device Implantation: “The Post-VAD Residual”

Journal of cardiac failure, 2021-05, Vol.27 (5), p.618-619

2021

Volltextzugriff (PDF)

Addition of Angiotensin-Converting Enzyme Inhibitors to Beta-Blockers Has a Distinct Effect on Hispanics Compared With African Americans and Whites With Heart Failure and Reduced Ejection Fraction: A Propensity Score–Matching Study

Journal of cardiac failure, 2015-06, Vol.21 (6), p.448-456

2015

Volltextzugriff (PDF)

Relaxin levels in pulmonary hypertension: A comparison between pulmonary arterial hypertension and diastolic heart failure-induced pulmonary hypertension

The Journal of heart and lung transplantation, 2013-03, Vol.32 (3), p.371-374

2013

Volltextzugriff (PDF)

Greater admissions, mortality and cost of heart failure in adults with congenital heart disease

Heart (British Cardiac Society), 2021-05, Vol.107 (10), p.807-813

2021

Volltextzugriff (PDF)

Ranolazine Improves Right Ventricular Function in Patients With Precapillary Pulmonary Hypertension: Results From a Double-Blind, Randomized, Placebo-Controlled Trial

Journal of cardiac failure, 2021-02, Vol.27 (2), p.253-257

2021

Volltextzugriff (PDF)

Right ventricular outflow tract velocity time integral-to-pulmonary artery systolic pressure ratio: a non-invasive metric of pulmonary arterial compliance differs across the spectrum of pulmonary hypertension

Pulmonary circulation, 2019-04, Vol.9 (2), p.1-10

2019

Volltextzugriff (PDF)

1 – 25 von 185

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(174)
Mit Volltextzugriff
(172)

Publikationsform

Sprache

Englisch
(185)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A comprehensive echocardiographic method for risk stratification in pulmonary arterial hypertension

Understanding Heart Failure

Serum Albumin Is a Marker of Myocardial Fibrosis, Adverse Pulsatile Aortic Hemodynamics, and Prognosis in Heart Failure With Preserved Ejection Fraction

Right ventricular response to pulsatile load is associated with early right heart failure and mortality after left ventricular assist device

Galectin-3 Levels Are Elevated and Predictive of Mortality in Pulmonary Hypertension

Pulmonary Hypertension in Heart Failure Patients

Pulmonary Hypertension in Advanced Heart Failure: Assessment and Management of the Failing RV and LV

Outcomes in World Health Organization Group II Pulmonary Hypertension: Mortality and Readmission Trends With Systolic and Preserved Ejection Fraction–Induced Pulmonary Hypertension

Novel Risk Model to Predict Emergency Department Associated Mortality for Patients Supported With a Ventricular Assist Device: The Emergency Department-Ventricular Assist Device Risk Score

Predicting Long Term Outcome in Patients Treated With Continuous Flow Left Ventricular Assist Device: The Penn—Columbia Risk Score

An Increasing Burden of Disease: Emergency Department Visits Among Patients With Ventricular Assist Devices From 2010 to 2017

Focused Cardiac Ultrasound in Place of Repeat Echocardiography: Reliability and Cost Implications

Comparison of Causes of Death After Heart Transplantation in Patients With Left Ventricular Ejection Fractions ≤35% Versus >35

The effect of transfusion of blood products on ventricular assist device support outcomes

Understanding Heart Failure

Symptom phenotypes in pulmonary arterial hypertension: The PAH “symptome”

Cold at the Core: Osborn Waves in Neurosarcoidosis-Induced Central Hypothermia

Systemic arterial properties in pulmonary hypertension

Latent Pulmonary Vascular Disease May Alter the Response to Therapeutic Atrial Shunt Device in Heart Failure

Changes in Pulmonary Vascular Resistance after Left Ventricular Assist Device Implantation: “The Post-VAD Residual”

Addition of Angiotensin-Converting Enzyme Inhibitors to Beta-Blockers Has a Distinct Effect on Hispanics Compared With African Americans and Whites With Heart Failure and Reduced Ejection Fraction: A Propensity Score–Matching Study

Relaxin levels in pulmonary hypertension: A comparison between pulmonary arterial hypertension and diastolic heart failure-induced pulmonary hypertension

Greater admissions, mortality and cost of heart failure in adults with congenital heart disease

Ranolazine Improves Right Ventricular Function in Patients With Precapillary Pulmonary Hypertension: Results From a Double-Blind, Randomized, Placebo-Controlled Trial

Right ventricular outflow tract velocity time integral-to-pulmonary artery systolic pressure ratio: a non-invasive metric of pulmonary arterial compliance differs across the spectrum of pulmonary hypertension

Suchergebnisse filtern